* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Cardiac Disease in Pregnancy
Saturated fat and cardiovascular disease wikipedia , lookup
Heart failure wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Cardiothoracic surgery wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Coronary artery disease wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Cardiac surgery wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Myocardial infarction wikipedia , lookup
Aortic stenosis wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Atrial septal defect wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Cardiac Disease in Pregnancy John G. Harkins M.D., F.A.C.O.G. Assistant Professor Department of Obstetrics and Gynecology The University of Texas Southwestern School of Medicine Austin, Texas Objectives • Provide an overview of normal cardiac • • physiology in pregnancy and how it differs from the nonpregnant state Identify common maternal cardiac diseases (anatomic and physiologic) Discuss rational and evidence based treatment algorithms for these maternal cardiac issues and strategies for optimizing maternal and fetal outcome Maternal Cardiac Physiology Maternal cardiac and circulatory adaptations to pregnancy begin early in the first trimester and do not return to baseline until at least 6 weeks postpartum Maternal Cardiac Physiology Cardiovascular Alterations • Increased blood volume – Average 40-45% increase in volume by third trimester; individual variation apparent with some nearly doubling – Marked increases with twins and higher order gestations Maternal Cardiac Physiology Cardiovascular Alterations • Expansion of maternal blood volume provides the following benefits: – Allows the perfusion of the hypertrophied uterus and associated vasculature – Protects maternal and fetal circulation against postural hypotension and impaired venous return to the heart – Allows for significant blood loss during parturition Maternal Cardiac Physiology Cardiovascular Alterations Maternal Cardiac Physiology Cardiovascular Alterations • Decreased systemic vascular resistance • Decreased blood pressure • Decreased pulmonary vascular resistance • Increased heart rate • Increased cardiac output CO = SV x HR Maternal Cardiac Physiology Cardiovascular Alterations Maternal Cardiac Disease • Valvular Cardiac Disease – Mitral Stenosis – Mitral Insufficiency – Aortic Stenosis – Aortic Insufficiency – Pulmonic Stenosis Maternal Cardiac Disease • Congenital Heart Disease – Septal Defects • Atrial Septal Defects • Ventricular Septal Defects • Atrioventricular Septal Defects – Patent Ductus Arteriosus • Cyanotic Congenital Heart Disease – Tetralogy of Fallot – Ebstein’s Anomaly Maternal Cardiac Disease • Pulmonary Hypertension – Eisenmenger syndrome • • • • • • Mitral Valve Prolapse Marfan Syndrome/Aortic Dissection Aortic Coarctation Infective Endocarditis Ischemic Heart Disease Myocardial Infarction New York Heart Association (NYHA) Classification (1979) • Class I – uncompromised – No symptoms of cardiac disease • Class II – limited symptomatology – These patients are asymptomatic at rest but develop symptoms (chest pain, shortness of breath, fatigue, palpitations) with physical exertion • Class III – marked symptomatology – These patients are asymptomatic at rest but become symptomatic with even minimal physical activity • Class IV – symptoms at rest Maternal Cardiac Disease • Predictors of cardiac complications in pregnancy include: – Prior heart failure, transient ischemic attack, stroke, or arrythmia – Left sided obstruction as defined by: • Mitral valve area < 2cm² • Aortic valve area < 1.5cm² • Aortic valve peak gradient > 30mm Hg – Ejection fraction < 40% – NYHA Class III or IV prior to pregnancy Mitral Stenosis • Most commonly caused by rheumatic • • • • endocarditis Relatively fixed cardiac output Degree of stenosis is directly associated with risk Patients with mitral stenosis are at risk for atrial fibrillation, mural thrombi, pulmonary edema, and passive pulmonary hypertension Epidurals and SVD generally advisable but must avoid drops in preload to maintain CO Mitral Stenosis Mitral Insufficiency • Incomplete coaptation of the mitral valve allows • • • regurgitation of blood from LV back into LA leading to LV hypertrophy Usually caused by Rheumatic fever, MVP, or LV dilatation (cause AND effect) Usually asymptomatic in nonpregnant patients Extremely well tolerated in pregnancy due to decrease in SVR (afterload) resulting in less regurgitation Mitral Insufficiency Aortic Stenosis • May be congenital (i.e., bicuspid aortic valve) or acquired • • • • • (rheumatic fever) A disease of fixed cardiac output In severe cases, cardiac output may not be able to adequately maintain cerebral or cardiac perfusion Limitation of physical activity during pregnancy is essential Any decrease in preload (orthostasis, α- adrenergic blockade from epidural, hemorrhage, etc.) may result in stroke or sudden cardiac death Maternal mortality 5-15% depending on severity of lesion Aortic Stenosis Aortic Insufficiency • Mostly rheumatic in origin but may also be • • secondary to connective tissue disease or congenital LV hypertrophy and dilatation are secondary to AI Very well tolerated in pregnancy due to: – Decrease in SVR (afterload) – Physiologic increase in HR allows less time for regurgitant backflow Aortic Insufficiency Pulmonic Stenosis • Usually congenital • Can be associated with Tetralogy of Fallot or Noonan syndrome • Can cause RA and RV enlargement • Severe stenosis associated with right sided heart failure and atrial arrythmias Pulmonic Stenosis Septal Defects • Atrial Septal Defect (ASD) – Most common congenital lesion seen in pregnancy – Rarely symptomatic – Characterized by high pulmonary blood flow and normal pulmonary artery pressure – Paradoxical embolism Atrial Septal Defect (ASD) Ventricular Septal Defect (VSD) • Size of defect is most important factor in • • determining severity and 90% close in childhood If effective size exceeds that of aortic valve, symptoms develop rapidly and must be surgically corrected Adults with unrepaired sizable VSDs can develop LV hypertrophy, LV failure, and pulmonary hypertension Ventricular Septal Defect Patent Ductus Arteriosus (PDA) • Uncommon in pregnant women due to high rate • • • of detection and repair in childhood Severity is related to size of PDA As with all high pressure left to right shunting, pulmonary hypertension can develop Sudden drops in SVR (massive hemorrhage, epidural, etc.) may cause reversal of flow through PDA and be fatal Patent Ductus Arteriosus Cyanotic Heart Disease • Congenital heart lesions that shunt blood from • • • the right heart to the left heart and bypass the pulmonary capillary bed This results in deoxygenated blood being placed back into the systemic circulation The magnitude of the shunting, and hence the degree of cyanosis, is inversely related to SVR When hypoxemia stimulates erythropoetic centers such that hematocrit is at or above 65%, pregnancy wastage is virtually 100% Tetralogy of Fallot • The most common cyanotic heart lesion encountered in pregnancy – – – – VSD Overriding aorta (receives blood from RV and LV) RV hypertrophy Pulmonary stenosis • Surgical correction allows for excellent • obstetrical outcomes Uncorrected Tetralogy of Fallot is associated with 4-15% maternal and 30% fetal mortality Tetralogy of Fallot Ebstein’s Anomaly • Few women with uncorrected Ebstein’s anomaly reach their reproductive years • Pregnancy increases volume overload and hence exacerbates RV failure and cyanosis • In the absence of significant cyanosis, pregnancy is otherwise well tolerated Ebstein’s Anomaly Pulmonary Hypertension • WHO Classification 2004 – Class I • Idiopathic • Familial • Associated with collagen vascular disorders, congenital left to right shunts, HIV disease, thyrotoxicosis, SCA, antiphospholipid antibody syndrome, portal hypertension – Class II – associated with left sided heart disease Pulmonary Hypertension – Class III – associated with lung disease • Chronic obstructive pulmonary disease (COPD) • Interstitial lung disease – Class IV – Pulmonary hypertension due to chronic thromboembolic disease • Class I disorders have poorest prognosis in pregnancy and 80% of maternal deaths occur postpartum Pulmonary Hypertension • Class II disorders are the most common in pregnancy (VSD, PDA, severe mitral stenosis) and are associated with better maternal outcome • Severe disease regardless of class is associated with at least a 50% chance of maternal mortality Pulmonary Hypertension • Management – Minimizing activity – Avoiding supine position as gestation progresses – Use of diuretics, O², and vasodilators to treat symptoms – At delivery, avoiding hypotension is critical as most maternal deaths in patients with pulmonary hypertension are due to decreased venous return to the heart Eisenmenger’s Syndrome • Occurs in the presence of pulmonary • • • hypertension caused by an underlying congenital left to right shunt (usually ASD, VSD, or PDA) As pulmonary hypertension worsens, PA pressure equals systemic pressure and the shunt becomes bidirectional or entirely right to left Eisenmenger’s syndrome is associated with a 30-50% chance of maternal mortality during pregnancy, delivery, or postpartum RV failure and cardiogenic shock is the most common cause of maternal mortality Eisenmenger’s Syndrome Mitral Valve Prolapse • Cardiac complications from MVP are rare • Pregnancy outcomes are excellent • ACOG specifically refers to MVP and states that MVP “never needs infective endocarditis prophylaxis” – ACOG Committee Opinion #421, Nov. 2008. Marfan Syndrome • Autosomal dominant connective tissue disorder • Manifestations include ocular, skeletal, and • • cardiovascular abnormalities In pregnancy, aortic root or splenic artery aneurysm or dissection is most common site of complications Aortic root dilatation of 40 mm is associated with up to a 50 % risk of maternal mortality Aortic Coarctation • Associated with VSD and PDA as well as • • intracranial aneurysms in the circle of Willis NYHA Class I or II have 3-4% risk of mortality Anomalous or bicuspid aortic valves, other associated cardiac lesions, aneursms in the circle of Willis or aortic aneurysms all increase maternal mortality to 15% Aortic Coarctation Infective Endocarditis Ischemic Heart Disease/ Myocardial Infarction • Incidence of pregnancy complicated by ischemic heart • • • • disease increasing Incidence of acute myocardial infarction in pregnancy estimated to be 1-6/100,000 Risk factors appear to be consistent with nonpregnant population Mortality risk adversely affected by pregnancy and increases with advancing gestational age Treatment is essentially standard and intervention warranted only for obstetrical indications